Medical and Health Science Journal

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Volume 18
Issue 1
Title Multiple sclerosis and nutrition: A condensed review
Author IL Labuschagne, R Blaauw
Abstract
Multiple sclerosis (MS) is a chronic, inflammatory, neurodegenerative demyelinating disease of the central nervous system (CNS).Inflammation is increased by hyper caloric Western-style diets, typically high in salt, animal fat, red meat, sugar-sweetened drinks, fried food, low in fibre, and lack of physical exercise. An anti-inflammatory dietary regimen, with or without administration of dietary supplements, thus supporting the general trend towards an amelioration of inflammatory status, should be considered. 
Understanding the role of gut microbiota in health and disease can lay the foundation to treat chronic diseases by modifying the composition of gut microbiota through the choice of a correct lifestyle, including dietary habits and possibly probiotic supplementation.
Evidences from experimental, epidemiologic and clinical studies support the potential linkage between poor vitamin D status and the risk of developing MS, as well as, an adverse disease course. Correcting vitamin D status seems plausible in MS patients. 
Citation
References
Rito Y, Torre-Villalvazo I, Flores J, Rivas V, Corona T1. Epigenetic in Multiple Sclerosis: Molecular mechanisms and dietary intervention. Cent Nerv Syst Agents Med Chem. 2016 Feb 26. [Epub ahead of print].

Riccio P, Rossano R. Nutrition Facts in Multiple Sclerosis. ASN Neuro. 2015:1-20.

Farinotti M, Vacchi L, Simi S, et al.  Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev. 2012 Dec 12;12:CD004192. doi: 10.1002/14651858.CD004192.pub3.

Desvergne B, Michalik L, Wahli E. Transcriptional regulation of metabolism Physiol Rev. 2006 Apr; 86(2):465-514.

Erridge C, Attina T, Spickett C M, Webb DJ. A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. American Journal of Clinical Nutrition. 2007;  86, 1286-1292.

Ghanim H, Abuaysheh S Sia CL, Korzeniewski K, et al.Increase in plasma endotoxin concentrations and the expressionof Toll-like receptors and suppressor of cytokine signaling-3 inmononuclear cells following a high-fat high-carbohydrate meal:Implications for insulin resistance. Diabetes Care, 2009; 32:2281-2287.

Margioris, A. N. Fatty acids and postprandial inflammation. Current Opinion in Clinical Nutrition and Metabolic Care, 2009; 12: 129-137.

Li B, Reynolds JM, Stout RD, et al.  Regulation of Th17 differentiation by epidermal fatty acid-binding protein. J Immunol [Internet]. 2009 Jun 15 [cited 2015];182(12):7625-7633. 

Li Y-H, Yang L-H, Sha K-H, Liu T-G, Zhang L-G, Liu X-X (2015). Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis. World J Gastroenterol [Internet]. 2015 Jun 14 [cited 2015];21(22):7008-7013.

Macias-Islas MA, Ortiz GG, Pacheco-Moises F, et al. Efficacy of fish oil on serum of TNF a, IL-1 b, and IL-6 oxidative stress markers in multiple sclerosis treated with interferonbeta-1b. Oxid Med Cell Longev 2013; 2013: ID709493.

Pantzaris MC, Loukaides GN, Ntzani EE, Patrikios IS. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open 2013; 3:e002170.

Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010 ; 39(2): 365-379. doi:10.1016/j.ecl.2010.02.010.

Thouvenot E, Orsini M, Daures JP, Camu W. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.  Eur J Neurol. 2015 Mar;22(3):564-9. doi: 10.1111/ene.12617. Epub 2014 Dec 20.

Jahromi SR, Sahraian MA, Togha M, et al. Iranian consensus on use of vitamin D in patients with multiple sclerosis. BMC Neurology (2016) 16:76.

Ascherio A, A, Munger KL, White R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014;71:306-14.

Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res 2014;7:69-87.

Riccio P,  Rossano R,  Larocca M. et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study. Exp Biol Med (Maywood) OnlineFirst, published on January 18, 2016 as doi:10.1177/1535370215618462.

Holmøy T & Øivind Torkildsen Ø. Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?, Expert Review of Neurotherapeutics, 2016:3, 233-235, DOI: 10.1586/14737175.2016.1146134.

Jiao Z, Fu Y, Fu J, Zhang F, Wang W. 1, 25-dihydroxy vitamin D3 promotes the apoptosis of inflammatory cells in acute experimental autoimmune encephalomyelitis: experiment with rats. Zhonghua Yi Xue Za Zhi. 2008; 88(33):2350-4. PMID: 9087699.

Pedersen LB, Nashold FE, Spach KM, Hayes CE. 1, 25‐dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res. 2007; 85(11): 2480-90. PMID: 17600374.

Mattner F, Smiroldo S, Galbiati F,  et al. Inhibition of Th1 development and treatment of chronic‐relapsing experimental allergic encephalomyelitis by a non‐hypercalcemic analogue of 1, 25‐dihydroxyvitamin D3. Eur J Immunol. 2000; 30(2):498-508. doi:10.1002/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q.

Muthian G, Raikwar HP, Rajasingh J, Bright JJ. 1, 25 dihydroxyvitamin‐D3 modulates JAK-STAT pathway in IL‐12/IFNγ axis leading to Th1 response inexperimental allergic encephalomyelitis. J Neurosci Res. 2006; 83(7):1299-309. doi:10.1002/jnr.20826.

Rinaldi AO, Sanseverino I, Purificato C, et al. Increased circulating levels of vitamin D binding protein in MS patients. Toxins. 2015; 7(1):129-37. doi:10.3390/toxins7010129.

Mullin GE. Vitamin A and immunity. Nutr Clin Pract 2011; 26: 495.

Hall JA, et al. The role of retinoic acid intolerance and immunity. Immunity 2011;35:13-22.
Bitarafan S, Saboor-Yaraghi A, Sahraian MA, et al. Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis. Arch Iran Med. 2015 Jul; 18(7):435-40. doi: 0151807/AIM.008.

Massa, J., O’Reilly, E. J., Munger, K. L., & Ascherio, A. Caffeine and alcohol intakes have no association with risk of multiple sclerosis. Multiple Sclerosis, 2015; 19: 53-58.

Hedstro¨m, A. K., Hillert, J., Olsson, T., & Alfredsson, L. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurology, 2014; 71: 300-305.

Florindo, M. Inflammatory cytokines and physical activity in multiple sclerosis. ISRN Neurology, 151-572. doi: 10.1155/ 2014/151572.

Petschow B,   Dore J, Hibberd P, et al.  Probiotics, prebiotics, and the host microbiome: the science of translation.  Ann. N.Y. Acad. Sci. 2013. ISSN 0077-8923.

Ríos-Covián D, Ruas-Madiedo P, Margolles A, et al.  Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front. Microbiol. 2016; 7:185. doi: 10.3389/fmicb.2016.00185

Chassaing B, &Gewirtz A T. Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicologic Pathology, 2014; 42: 49-53.

Cani PD, & Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Current Pharmaceutical Design, 2009; 15, 1546-1558.

Wu GD. Chen J, Hoffmann C, et al.  Linking long-term dietary patterns with gut microbial enterotypes. Science, 2011; 334: 105-108.

Tremaroli V & Baừckhed F. Functional interactions between the gut microbiota and host metabolism. Nature, 2012;  489: 242-249.

Panda S, Guarner F, Manichanh C.  Structure and functions of the gut microbiome. Endocrine, Metabolic & Immune Disorders - Drug Targets, 2014. PMID: 25022563.

Honda K & Littman DR. The Microbiome in Infectious Disease and Inflammation. Annu. Rev. Immunol. 2012; 30:759-95.

Fleming JO, Isaak A, Lee JE, et al. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler, 2011; 17:743e54.

Kouchaki E , Tamtaji OR, Salami M, et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition ; 2016:  1-5.

Rothhammer V & Quintana FJ. Environmental control of autoimmune inflammation in the central nervous system  RSS Current Opinion in Immunology, 2016-12-01, Volume 43, Pages 46-53.

Lamas B et al.: CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med 2016, 22(6):598-605.

Smits LP, Bouter KE, de Vos WM, et al. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013 Nov;145(5):946-53. doi: 10.1053/j.gastro.2013.08.058. Epub 2013 Sep 7. Review.

Baily. J. Multiple Sclerosis Society of Canada. Healthy Eating: A guide for people with MS. 2008.
National Multiple Sclerosis Society. Diet & Nutrition. Eating healthy to take charge of your health. Available at: http://www.nationalmssociety.org/Living-Well-With-MS/Health-Wellness/Diet-Nutrition#section-0. Accessed on 15 July 2015.

Opperman M. What health professionals should know about omega-3 fatty acid supplements. S Afr J Clin Nutr 2013; 26(2):6-11.

Riccio P, Rosano R, Larocca M. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study. Exp Biol Med (Maywood) OnlineFirst, published on January 18, 2016 as doi:10.1177/1535370215618462.

Okada Y, Tsuzuki Y, Ueda T. Trans fatty acids in diets act as a precipitating factor for gut inflammation? Journal of Gastroenterology and Hepatology 2013; 28 (Suppl. 4): 29-32. 

Serhan CN, Dalli J, Colas RA, et al.  Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim Biophys Acta 2015; 1851:397-413. (Review)

Montonen J, Boeing H, Fritsche A , et al. Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress. European Journal of Nutrition, 2013; 52: 337-345.

Stenson, W. F.  The universe of arachidonic acid metabolites in inflammatory bowel disease: Can we tell the good from the bad? Current Opinion in Gastroenterology, 2014; 30: 347-351.

Williams R, Buchheit C L, Berman N et al. Pathogenic implications of iron accumulation in multiple sclerosis. Journal of Neurochemistry, 2012; 120: 7-25.

Shokryazdan P, Jahromi MF, Navidshad B et al. Effects of prebiotics on immune system and cytokine expression. Review. Med Microbiol Immunol, 2016; DOI 10.1007/s00430-016-0481-y.

Ascherio A, Munger KL, White R, Ko¨chert K, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71:306-14.

Yin, K., & Agrawal, D. K.  Vitamin D and inflammatory diseases. Journal of Inflammation Research, 2014; 7: 69-87.

Salinthone S, Yadav V, Schillace RV, et al. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS One 2010; 5:e13058.

Smolders J, Damoiseaux J, Menheere P. Vitamin D as an immune modulator in multiple sclerosis, a review. Journal of Neuroimmunology, 2008; 194: 7-17.

Pierrot-Deseilligny C. Clinical implications of a possible role of vitamin D in multiple sclerosis. Journal of Neurology, 2009; 256: 1468-1479.

Cantorna MT.  Vitamin D, multiple sclerosis and inflammatory bowel disease. Archives of Biochemistry and Biophysics, 2012; 523: 103-106.

Erridge, C., Attina, T., Spickett, C. M., & Webb, D. J.  A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. American Journal of Clinical Nutrition, 2007; 86, 1286-1292.

Ghanim, H., Abuaysheh, S., Sia, C. L., Korzeniewski, K., Thaipisuttikul P, Galvin JE. Use of medical foods and nutritional approaches in the treatment of Alzheimer’s disease. Clin Pract (Lond) [Internet]. 2012 Mar [cited 2015];9(2):199-209. Available from:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3556480&tool=pmcentrez&rendertype=abstract).

Margioris, A. N.  Fatty acids and postprandial inflammation. Current Opinion in Clinical Nutrition and Metabolic Care, 2009; 12: 129-137.

Shivappa N, Hebert JR, Behrooz M, Rashidkhani B. Dietary Inflammatory Index and Risk of Multiple Sclerosis in a Case-Control Study from Iran. Neuroepidemiology. 2016; 47(1):26-31. doi: 10.1159/000445874. Epub 2016 Jul 1.

Cheng G, Zhang X, Gao D, Jiang X, Dong W. Resveratrol inhibits MMP- 9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neurosci Lett 2009;451:105-8.

Wang, S., Moustaid-Moussa, N., Chen, L., et al. Novel insights of dietary polyphenols and obesity. The Journal of Nutritional Biochemistry, 2014; 25(1): 1-18. doi: 10.1016/j.jnutbio.2013.09.001.

Wu C, Yosef N, Thalhamer T, et al.  Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature, 2013; 496: 513-517.

Kleinewietfeld M, Manzel A, Titze J, et al.  Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature, 2013;  496: 518-522.

Hedstro¨m, A. K., Olsson, T., & Alfredsson, L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Multiple Sclerosis, 2012; 18: 1334-1336.

Cheng G, Zhang X, Gao D, Jiang X, Dong W. Resveratrol inhibits MMP- 9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neurosci Lett 2009; 451:105-8.

Das S, Das DK. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets 2007; 6:168-73.

Keywords Multiple sclerosis, diet, nutrition, vitamin D, anti-inflammatory diet
DOI http://dx.doi.org/10.15208/mhsj.2017.04
Pages 28-36
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Share
Search in articles
Statistics
Journal Published articles
MHSJ 940
Journal Hits
MHSJ 2213262
Journal Downloads
MHSJ 16957
Total users online -